146 related articles for article (PubMed ID: 10834538)
1. Expression of vascular endothelial growth factor in renal cell carcinomas.
Paradis V; Lagha NB; Zeimoura L; Blanchet P; Eschwege P; Ba N; Benoît G; Jardin A; Bedossa P
Virchows Arch; 2000 Apr; 436(4):351-6. PubMed ID: 10834538
[TBL] [Abstract][Full Text] [Related]
2. Histopathological analysis of angiogenic factors in renal cell carcinoma.
Yagasaki H; Kawata N; Takimoto Y; Nemoto N
Int J Urol; 2003 Apr; 10(4):220-7. PubMed ID: 12657102
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor - its relation to neovascularization and their significance as prognostic factors in renal cell carcinoma.
Song KH; Song J; Jeong GB; Kim JM; Jung SH; Song J
Yonsei Med J; 2001 Oct; 42(5):539-46. PubMed ID: 11675683
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality.
Baltaci S; Orhan D; Göğüş C; Filiz E; Tulunay O; Göğüş O
Eur Urol; 2003 Jul; 44(1):76-81; discussion 81. PubMed ID: 12814678
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases.
Zhang X; Yamashita M; Uetsuki H; Kakehi Y
Int J Urol; 2002 Sep; 9(9):509-14. PubMed ID: 12410931
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression.
Lee JS; Kim HS; Jung JJ; Park CS; Lee MC
J Surg Oncol; 2001 May; 77(1):55-60. PubMed ID: 11344484
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].
Sato K; Kato T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):389-94. PubMed ID: 9063473
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas.
Hemmerlein B; Kugler A; Ozisik R; Ringert RH; Radzun HJ; Thelen P
Virchows Arch; 2001 Nov; 439(5):645-52. PubMed ID: 11764385
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
11. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma.
Tomisawa M; Tokunaga T; Oshika Y; Tsuchida T; Fukushima Y; Sato H; Kijima H; Yamazaki H; Ueyama Y; Tamaoki N; Nakamura M
Eur J Cancer; 1999 Jan; 35(1):133-7. PubMed ID: 10211101
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas.
Kilicarslan AB; Ogus M; Arici C; Pestereli HE; Cakir M; Karpuzoglu G
APMIS; 2003 Mar; 111(3):439-43. PubMed ID: 12752224
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.
Huang SM; Lee JC; Wu TJ; Chow NH
World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180
[TBL] [Abstract][Full Text] [Related]
17. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma.
Yilmazer D; Han U; Onal B
Int Urol Nephrol; 2007; 39(3):691-8. PubMed ID: 17180739
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
Jacobsen J; Grankvist K; Rasmuson T; Bergh A; Landberg G; Ljungberg B
BJU Int; 2004 Feb; 93(3):297-302. PubMed ID: 14764126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]